anti fibronectin Search Results


96
Santa Cruz Biotechnology anti fibronectin
Anti Fibronectin, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti fibronectin/product/Santa Cruz Biotechnology
Average 96 stars, based on 1 article reviews
anti fibronectin - by Bioz Stars, 2026-05
96/100 stars
  Buy from Supplier

99
Danaher Inc anti fibronectin
Anti Fibronectin, supplied by Danaher Inc, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti fibronectin/product/Danaher Inc
Average 99 stars, based on 1 article reviews
anti fibronectin - by Bioz Stars, 2026-05
99/100 stars
  Buy from Supplier

94
Novus Biologicals fibronectin
Cadherin-11 knockdown reduces the expression of <t>fibronectin.</t> HMSCs were seeded at 1 × 10 4 cells/cm 2 and evaluated after days 1 and 14. ( A ) Western blot analysis of fibronectin on day 1 shows increased expression in cadherin-11-knockdown cells (sh-CDH11) compared with the wild type and scrambled (sh-SCR) controls. GAPDH is shown as a loading control. ( B ) Immunofluorescence micrographs of fibronectin (white) at day 1 also show increased expression in the sh-CDH11 cells compared with the wild type. ( C ) Western blot analysis on day 14 shows that the fibronectin expression persists in sh-CDH11 cells compared with the wild type and sh-SCR. ( D ) Immunofluorescence micrographs of fibronectin (white) at day 14 confirm the increased expression compared to the wild type. Nuclei were counterstained with DAPI (blue). Data are representative of at least 3 independent experiments with similar results. Scale bars represent 100 μm.
Fibronectin, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/fibronectin/product/Novus Biologicals
Average 94 stars, based on 1 article reviews
fibronectin - by Bioz Stars, 2026-05
94/100 stars
  Buy from Supplier

92
R&D Systems fibronectin antibody
Fig. 3. Overexpression of Snail in ARPE-19 cells induced EMT. ARPE-19 cells were transfected with pReceiver-Snail or pReceiver-control for 48 h. QRT-PCR and Immunoblotting were used to examine the expression of Snail, E-cadherin, ZO-1, a-SMA and fibronectin. (A) QRT-PCR analysis showed the increased Snail, fibronectin and a- SMA mRNA expression and decreased E-cadherin and ZO-1 mRNA expression. ⁄⁄P < 0.01 vs pReceiver-control. (B) Immunoblotting confirmed the expression of these EMT markers at protein levels.
Fibronectin Antibody, supplied by R&D Systems, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/fibronectin antibody/product/R&D Systems
Average 92 stars, based on 1 article reviews
fibronectin antibody - by Bioz Stars, 2026-05
92/100 stars
  Buy from Supplier

93
R&D Systems fn1 neutralizing antibody fn1 ab
Transcriptome analysis revealed the central role of the ECM-PI3K pathway in pancreatic cancer metastasis. (A) Volcano plot of differentially expressed genes (DEGs), showing 248 DEGs between pancreatic cancer tissues (PANC) and adjacent normal tissues (CTR), with 153 genes upregulated and 95 genes downregulated. (B) Hierarchical clustering heatmap of the top 100 DEGs, demonstrating differences in gene expression patterns between PANC and CTR tissues. (C) Results of KEGG functional enrichment analysis, indicating that the DEGs are primarily involved in signaling pathways such as ECM-receptor interaction, Cytoskeleton in muscle cells, Focal adhesion, and P13K/AKT signaling pathway. (D) GO analysis results, showing significant enrichment of DEGs in processes related to adhesion and ECM. (E, F) CytoHubba analysis results, revealing <t>FN1</t> as a core hub gene in the P13K/AKT signaling pathway.
Fn1 Neutralizing Antibody Fn1 Ab, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/fn1 neutralizing antibody fn1 ab/product/R&D Systems
Average 93 stars, based on 1 article reviews
fn1 neutralizing antibody fn1 ab - by Bioz Stars, 2026-05
93/100 stars
  Buy from Supplier

95
Novus Biologicals antibodies for fn
Transcriptome analysis revealed the central role of the ECM-PI3K pathway in pancreatic cancer metastasis. (A) Volcano plot of differentially expressed genes (DEGs), showing 248 DEGs between pancreatic cancer tissues (PANC) and adjacent normal tissues (CTR), with 153 genes upregulated and 95 genes downregulated. (B) Hierarchical clustering heatmap of the top 100 DEGs, demonstrating differences in gene expression patterns between PANC and CTR tissues. (C) Results of KEGG functional enrichment analysis, indicating that the DEGs are primarily involved in signaling pathways such as ECM-receptor interaction, Cytoskeleton in muscle cells, Focal adhesion, and P13K/AKT signaling pathway. (D) GO analysis results, showing significant enrichment of DEGs in processes related to adhesion and ECM. (E, F) CytoHubba analysis results, revealing <t>FN1</t> as a core hub gene in the P13K/AKT signaling pathway.
Antibodies For Fn, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/antibodies for fn/product/Novus Biologicals
Average 95 stars, based on 1 article reviews
antibodies for fn - by Bioz Stars, 2026-05
95/100 stars
  Buy from Supplier

93
Novus Biologicals hfn7 1 monoclonal antibody
Transcriptome analysis revealed the central role of the ECM-PI3K pathway in pancreatic cancer metastasis. (A) Volcano plot of differentially expressed genes (DEGs), showing 248 DEGs between pancreatic cancer tissues (PANC) and adjacent normal tissues (CTR), with 153 genes upregulated and 95 genes downregulated. (B) Hierarchical clustering heatmap of the top 100 DEGs, demonstrating differences in gene expression patterns between PANC and CTR tissues. (C) Results of KEGG functional enrichment analysis, indicating that the DEGs are primarily involved in signaling pathways such as ECM-receptor interaction, Cytoskeleton in muscle cells, Focal adhesion, and P13K/AKT signaling pathway. (D) GO analysis results, showing significant enrichment of DEGs in processes related to adhesion and ECM. (E, F) CytoHubba analysis results, revealing <t>FN1</t> as a core hub gene in the P13K/AKT signaling pathway.
Hfn7 1 Monoclonal Antibody, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/hfn7 1 monoclonal antibody/product/Novus Biologicals
Average 93 stars, based on 1 article reviews
hfn7 1 monoclonal antibody - by Bioz Stars, 2026-05
93/100 stars
  Buy from Supplier

93
Novus Biologicals factor thy 1 ox 7 mouse monoclonal novus biologicals
Transcriptome analysis revealed the central role of the ECM-PI3K pathway in pancreatic cancer metastasis. (A) Volcano plot of differentially expressed genes (DEGs), showing 248 DEGs between pancreatic cancer tissues (PANC) and adjacent normal tissues (CTR), with 153 genes upregulated and 95 genes downregulated. (B) Hierarchical clustering heatmap of the top 100 DEGs, demonstrating differences in gene expression patterns between PANC and CTR tissues. (C) Results of KEGG functional enrichment analysis, indicating that the DEGs are primarily involved in signaling pathways such as ECM-receptor interaction, Cytoskeleton in muscle cells, Focal adhesion, and P13K/AKT signaling pathway. (D) GO analysis results, showing significant enrichment of DEGs in processes related to adhesion and ECM. (E, F) CytoHubba analysis results, revealing <t>FN1</t> as a core hub gene in the P13K/AKT signaling pathway.
Factor Thy 1 Ox 7 Mouse Monoclonal Novus Biologicals, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/factor thy 1 ox 7 mouse monoclonal novus biologicals/product/Novus Biologicals
Average 93 stars, based on 1 article reviews
factor thy 1 ox 7 mouse monoclonal novus biologicals - by Bioz Stars, 2026-05
93/100 stars
  Buy from Supplier

93
R&D Systems human fibronectin 1 mouse monoclonal antibodies
Transcriptome analysis revealed the central role of the ECM-PI3K pathway in pancreatic cancer metastasis. (A) Volcano plot of differentially expressed genes (DEGs), showing 248 DEGs between pancreatic cancer tissues (PANC) and adjacent normal tissues (CTR), with 153 genes upregulated and 95 genes downregulated. (B) Hierarchical clustering heatmap of the top 100 DEGs, demonstrating differences in gene expression patterns between PANC and CTR tissues. (C) Results of KEGG functional enrichment analysis, indicating that the DEGs are primarily involved in signaling pathways such as ECM-receptor interaction, Cytoskeleton in muscle cells, Focal adhesion, and P13K/AKT signaling pathway. (D) GO analysis results, showing significant enrichment of DEGs in processes related to adhesion and ECM. (E, F) CytoHubba analysis results, revealing <t>FN1</t> as a core hub gene in the P13K/AKT signaling pathway.
Human Fibronectin 1 Mouse Monoclonal Antibodies, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human fibronectin 1 mouse monoclonal antibodies/product/R&D Systems
Average 93 stars, based on 1 article reviews
human fibronectin 1 mouse monoclonal antibodies - by Bioz Stars, 2026-05
93/100 stars
  Buy from Supplier

96
Proteintech anti fn1 rabbit polyclonal primary antibody
A. UMAP clustering of combined Xenium data sets from diabetic db/db and diabetic mice treated with DAPA for 6 weeks (n=4). B. Dot plot showing the cell specific markers from combined analysis of Xenium data sets. C. UMAP plot showing clustering of different cell types in aorta from db/db and db/dbDAPA mice. D. Representative Xenium data showing distribution of cell specific markers of SMC ( Myh11 ), fibroblast ( Dcn ) and endothelial cells ( Pecam1 ) in a representative aorta from one of the db/dbDAPA mice. E. Aortic cell clusters are depicted clearly in aortic sections in Xenium data sets from db/db and db/dbDAPA group. F-H. Representative images of Xenium data from db/db and db/dbDAPA aortas showing the expression of contractile ( Myh11 ) and Fibrosis markers ( <t>Fn1</t> and Col1a1 ). I-L. Violin plots depicting expression of contractile ( Myh11 , Acta2 ), and fibrosis associated genes ( Fn1, Col1a1 ) in db/db and db/dbDAPA groups (showing DAPA reduces Col1a1 fibrosis marker).
Anti Fn1 Rabbit Polyclonal Primary Antibody, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti fn1 rabbit polyclonal primary antibody/product/Proteintech
Average 96 stars, based on 1 article reviews
anti fn1 rabbit polyclonal primary antibody - by Bioz Stars, 2026-05
96/100 stars
  Buy from Supplier

94
R&D Systems anti fibronectin
A. UMAP clustering of combined Xenium data sets from diabetic db/db and diabetic mice treated with DAPA for 6 weeks (n=4). B. Dot plot showing the cell specific markers from combined analysis of Xenium data sets. C. UMAP plot showing clustering of different cell types in aorta from db/db and db/dbDAPA mice. D. Representative Xenium data showing distribution of cell specific markers of SMC ( Myh11 ), fibroblast ( Dcn ) and endothelial cells ( Pecam1 ) in a representative aorta from one of the db/dbDAPA mice. E. Aortic cell clusters are depicted clearly in aortic sections in Xenium data sets from db/db and db/dbDAPA group. F-H. Representative images of Xenium data from db/db and db/dbDAPA aortas showing the expression of contractile ( Myh11 ) and Fibrosis markers ( <t>Fn1</t> and Col1a1 ). I-L. Violin plots depicting expression of contractile ( Myh11 , Acta2 ), and fibrosis associated genes ( Fn1, Col1a1 ) in db/db and db/dbDAPA groups (showing DAPA reduces Col1a1 fibrosis marker).
Anti Fibronectin, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti fibronectin/product/R&D Systems
Average 94 stars, based on 1 article reviews
anti fibronectin - by Bioz Stars, 2026-05
94/100 stars
  Buy from Supplier

Image Search Results


Cadherin-11 knockdown reduces the expression of fibronectin. HMSCs were seeded at 1 × 10 4 cells/cm 2 and evaluated after days 1 and 14. ( A ) Western blot analysis of fibronectin on day 1 shows increased expression in cadherin-11-knockdown cells (sh-CDH11) compared with the wild type and scrambled (sh-SCR) controls. GAPDH is shown as a loading control. ( B ) Immunofluorescence micrographs of fibronectin (white) at day 1 also show increased expression in the sh-CDH11 cells compared with the wild type. ( C ) Western blot analysis on day 14 shows that the fibronectin expression persists in sh-CDH11 cells compared with the wild type and sh-SCR. ( D ) Immunofluorescence micrographs of fibronectin (white) at day 14 confirm the increased expression compared to the wild type. Nuclei were counterstained with DAPI (blue). Data are representative of at least 3 independent experiments with similar results. Scale bars represent 100 μm.

Journal: Stem Cells

Article Title: Cadherin-11 Influences Differentiation in Human Mesenchymal Stem Cells by Regulating the Extracellular Matrix Via the TGFβ1 Pathway

doi: 10.1093/stmcls/sxac026

Figure Lengend Snippet: Cadherin-11 knockdown reduces the expression of fibronectin. HMSCs were seeded at 1 × 10 4 cells/cm 2 and evaluated after days 1 and 14. ( A ) Western blot analysis of fibronectin on day 1 shows increased expression in cadherin-11-knockdown cells (sh-CDH11) compared with the wild type and scrambled (sh-SCR) controls. GAPDH is shown as a loading control. ( B ) Immunofluorescence micrographs of fibronectin (white) at day 1 also show increased expression in the sh-CDH11 cells compared with the wild type. ( C ) Western blot analysis on day 14 shows that the fibronectin expression persists in sh-CDH11 cells compared with the wild type and sh-SCR. ( D ) Immunofluorescence micrographs of fibronectin (white) at day 14 confirm the increased expression compared to the wild type. Nuclei were counterstained with DAPI (blue). Data are representative of at least 3 independent experiments with similar results. Scale bars represent 100 μm.

Article Snippet: Primary antibodies were against: type VI collagen (rabbit clone, 1:1000; Genetex, GTX109963), fibronectin (rabbit clone, 1:1000; Novus Biologicals, NBP1-91258), cadherin-11 (rabbit clone, 1:1000; Thermo Fisher Scientific, 71-7600), or GAPDH (mouse clone, 1:1000; Santa Cruz Biotechnology, SC-365062).

Techniques: Knockdown, Expressing, Western Blot, Control, Immunofluorescence

Fig. 3. Overexpression of Snail in ARPE-19 cells induced EMT. ARPE-19 cells were transfected with pReceiver-Snail or pReceiver-control for 48 h. QRT-PCR and Immunoblotting were used to examine the expression of Snail, E-cadherin, ZO-1, a-SMA and fibronectin. (A) QRT-PCR analysis showed the increased Snail, fibronectin and a- SMA mRNA expression and decreased E-cadherin and ZO-1 mRNA expression. ⁄⁄P < 0.01 vs pReceiver-control. (B) Immunoblotting confirmed the expression of these EMT markers at protein levels.

Journal: Biochemical and biophysical research communications

Article Title: Overexpression of Snail in retinal pigment epithelial triggered epithelial-mesenchymal transition.

doi: 10.1016/j.bbrc.2014.02.119

Figure Lengend Snippet: Fig. 3. Overexpression of Snail in ARPE-19 cells induced EMT. ARPE-19 cells were transfected with pReceiver-Snail or pReceiver-control for 48 h. QRT-PCR and Immunoblotting were used to examine the expression of Snail, E-cadherin, ZO-1, a-SMA and fibronectin. (A) QRT-PCR analysis showed the increased Snail, fibronectin and a- SMA mRNA expression and decreased E-cadherin and ZO-1 mRNA expression. ⁄⁄P < 0.01 vs pReceiver-control. (B) Immunoblotting confirmed the expression of these EMT markers at protein levels.

Article Snippet: The primary antibodies used were as follows: 1:500 E-cadherin antibody and 1:1000 fibronectin antibody (R&D systems, Inc., USA), 1:1000 Snail antibody (Abcam Ltd., Cambridge, USA), 1:1000 a-SMA antibody (Sigma–Aldrich, MO, USA), 1:1000 ZO-1 antibody (Invitrogen, Carlsbad, CA), and 1:5000 GAPDH (Good HERE, Hangzhou, China).

Techniques: Over Expression, Transfection, Control, Quantitative RT-PCR, Western Blot, Expressing

Transcriptome analysis revealed the central role of the ECM-PI3K pathway in pancreatic cancer metastasis. (A) Volcano plot of differentially expressed genes (DEGs), showing 248 DEGs between pancreatic cancer tissues (PANC) and adjacent normal tissues (CTR), with 153 genes upregulated and 95 genes downregulated. (B) Hierarchical clustering heatmap of the top 100 DEGs, demonstrating differences in gene expression patterns between PANC and CTR tissues. (C) Results of KEGG functional enrichment analysis, indicating that the DEGs are primarily involved in signaling pathways such as ECM-receptor interaction, Cytoskeleton in muscle cells, Focal adhesion, and P13K/AKT signaling pathway. (D) GO analysis results, showing significant enrichment of DEGs in processes related to adhesion and ECM. (E, F) CytoHubba analysis results, revealing FN1 as a core hub gene in the P13K/AKT signaling pathway.

Journal: Frontiers in Oncology

Article Title: FN1 from cancer-associated fibroblasts orchestrates pancreatic cancer metastasis via integrin-PI3K/AKT signaling

doi: 10.3389/fonc.2025.1595523

Figure Lengend Snippet: Transcriptome analysis revealed the central role of the ECM-PI3K pathway in pancreatic cancer metastasis. (A) Volcano plot of differentially expressed genes (DEGs), showing 248 DEGs between pancreatic cancer tissues (PANC) and adjacent normal tissues (CTR), with 153 genes upregulated and 95 genes downregulated. (B) Hierarchical clustering heatmap of the top 100 DEGs, demonstrating differences in gene expression patterns between PANC and CTR tissues. (C) Results of KEGG functional enrichment analysis, indicating that the DEGs are primarily involved in signaling pathways such as ECM-receptor interaction, Cytoskeleton in muscle cells, Focal adhesion, and P13K/AKT signaling pathway. (D) GO analysis results, showing significant enrichment of DEGs in processes related to adhesion and ECM. (E, F) CytoHubba analysis results, revealing FN1 as a core hub gene in the P13K/AKT signaling pathway.

Article Snippet: FN1 neutralizing antibody (FN1-Ab) was purchased from R&D Systems (Cat# MAB19182).

Techniques: Gene Expression, Functional Assay, Protein-Protein interactions

Single-cell sequencing identifies specific expression patterns of PI3K-related genes including FN1 in fibroblasts of metastatic samples. (A) UMAP plot displaying the sub-cell types in the primary pancreatic cancer (stiu) and liver metastasis (meta) samples from the single-cell RNA sequencing dataset GSE156405 . (B) UMAP plot showing the expression patterns of different groups in primary pancreatic cancer (stiu) and liver metastasis (meta) samples. (C) Cell proportion plot illustrating the distribution of different cell types in stiu and meta samples. (D) Bubble plot representing the relationship between different sub-cell types and characteristic gene expression. The color of the bubbles ranges from white to blue, representing gene expression percentages of 0%, 25%, 50%, and 75%, respectively. The size of the bubbles indicates the average expression level, ranging from a minimum to a maximum representing average expression values from 0 to 2. (E) KEGG enrichment analysis of DEGs in alveolar epithelial cells. (F) KEGG enrichment analysis of DEGs in fibroblasts. (G) Violin plot showing the expression patterns of PI3K-related genes (FN1, THBS2, COL1A1, COL1A2, and COL6A3) in different cell types and groups in fibroblasts.

Journal: Frontiers in Oncology

Article Title: FN1 from cancer-associated fibroblasts orchestrates pancreatic cancer metastasis via integrin-PI3K/AKT signaling

doi: 10.3389/fonc.2025.1595523

Figure Lengend Snippet: Single-cell sequencing identifies specific expression patterns of PI3K-related genes including FN1 in fibroblasts of metastatic samples. (A) UMAP plot displaying the sub-cell types in the primary pancreatic cancer (stiu) and liver metastasis (meta) samples from the single-cell RNA sequencing dataset GSE156405 . (B) UMAP plot showing the expression patterns of different groups in primary pancreatic cancer (stiu) and liver metastasis (meta) samples. (C) Cell proportion plot illustrating the distribution of different cell types in stiu and meta samples. (D) Bubble plot representing the relationship between different sub-cell types and characteristic gene expression. The color of the bubbles ranges from white to blue, representing gene expression percentages of 0%, 25%, 50%, and 75%, respectively. The size of the bubbles indicates the average expression level, ranging from a minimum to a maximum representing average expression values from 0 to 2. (E) KEGG enrichment analysis of DEGs in alveolar epithelial cells. (F) KEGG enrichment analysis of DEGs in fibroblasts. (G) Violin plot showing the expression patterns of PI3K-related genes (FN1, THBS2, COL1A1, COL1A2, and COL6A3) in different cell types and groups in fibroblasts.

Article Snippet: FN1 neutralizing antibody (FN1-Ab) was purchased from R&D Systems (Cat# MAB19182).

Techniques: Sequencing, Expressing, RNA Sequencing, Gene Expression

Core mechanisms of CAFs in pancreatic cancer metastasis. (A) UMAP plot displaying fibroblast subpopulations by cluster. (B) UMAP plot showing the distribution of fibroblast subpopulations by group. (C) Proportion plot illustrating the cell proportions by cell subpopulation and group. (D) Identification of the CAFs subpopulation among fibroblast subpopulations. (E) UMAP visualization analysis, displaying the expression patterns of FN1, THBS2, COL1A1, COL1A2, and COL6A3 in the stiu and meta groups.

Journal: Frontiers in Oncology

Article Title: FN1 from cancer-associated fibroblasts orchestrates pancreatic cancer metastasis via integrin-PI3K/AKT signaling

doi: 10.3389/fonc.2025.1595523

Figure Lengend Snippet: Core mechanisms of CAFs in pancreatic cancer metastasis. (A) UMAP plot displaying fibroblast subpopulations by cluster. (B) UMAP plot showing the distribution of fibroblast subpopulations by group. (C) Proportion plot illustrating the cell proportions by cell subpopulation and group. (D) Identification of the CAFs subpopulation among fibroblast subpopulations. (E) UMAP visualization analysis, displaying the expression patterns of FN1, THBS2, COL1A1, COL1A2, and COL6A3 in the stiu and meta groups.

Article Snippet: FN1 neutralizing antibody (FN1-Ab) was purchased from R&D Systems (Cat# MAB19182).

Techniques: Expressing

CAF-derived FN1 promotes invasion and migration of pancreatic cancer cells. (A) Schematic diagram of the CAFs-PANC1 co-culture model. (B) ELISA results showing changes in IL-6, IL-8, and MMP2 levels secreted by CAFs before and after TGF-β induction. (C) ELISA results demonstrating changes in FN1 levels secreted by CAFs before and after treatment with FN1 neutralizing antibody (FN1-Ab). (D) Transwell migration assay showing changes in the number of migrated cells in the FN1-Ab group compared to the control group. (E) Statistics of migration rates from the Transwell migration assay. (F) Transwell invasion assay showing changes in the number of invading cells in the FN1-Ab group compared to the control group. (G) Statistics of invasion rates from the Transwell invasion assay.

Journal: Frontiers in Oncology

Article Title: FN1 from cancer-associated fibroblasts orchestrates pancreatic cancer metastasis via integrin-PI3K/AKT signaling

doi: 10.3389/fonc.2025.1595523

Figure Lengend Snippet: CAF-derived FN1 promotes invasion and migration of pancreatic cancer cells. (A) Schematic diagram of the CAFs-PANC1 co-culture model. (B) ELISA results showing changes in IL-6, IL-8, and MMP2 levels secreted by CAFs before and after TGF-β induction. (C) ELISA results demonstrating changes in FN1 levels secreted by CAFs before and after treatment with FN1 neutralizing antibody (FN1-Ab). (D) Transwell migration assay showing changes in the number of migrated cells in the FN1-Ab group compared to the control group. (E) Statistics of migration rates from the Transwell migration assay. (F) Transwell invasion assay showing changes in the number of invading cells in the FN1-Ab group compared to the control group. (G) Statistics of invasion rates from the Transwell invasion assay.

Article Snippet: FN1 neutralizing antibody (FN1-Ab) was purchased from R&D Systems (Cat# MAB19182).

Techniques: Derivative Assay, Migration, Co-Culture Assay, Enzyme-linked Immunosorbent Assay, Transwell Migration Assay, Control, Transwell Invasion Assay

The FN1-ITG-PI3K/AKT axis promotes invasion and migration of pancreatic cancer cells. (A, B) GEPIA database analysis revealing a significant positive correlation between FN1 expression and the expression of key genes in the PI3K/AKT pathway (PIK3CA, AKT1). (C, D) Western blot results showing changes in phosphorylation levels of p-AKT and p-PI3K in the FN1-Ab group. The Western blot results demonstrated the changes in the phosphorylation levels of p-AKT and p-PI3K in the FN1-Ab groups of PANC-1 and BXPC-3 cells. (E, F) Statistical data corresponding to (C, D) . (G, H) mRNA expression changes of integrin genes (ITGA2, ITGB4, ITGA3) before and after treatment with an integrin inhibitor (ITG-Inh). The changes in mRNA expression of integrin genes ITGA2 , ITGB4 , and ITGA3 in PANC-1 and BXPC-3 cells before and after treatment with the integrin inhibitor ITG-Inh. (I, J) Western blot results demonstrating changes in protein levels of p-AKT and p-PI3K in the ITG-Inh group compared to the control group (ITG-Con). The Western blot results indicated that in PANC-1 and BXPC-3 cells, compared with the control group (ITG-CON), the protein levels of p-AKT and p-PI3K in the ITG-Inh group were altered. (K, L) Statistical data corresponding to (I, J) . (M, N) Changes in invasion ability after combined inhibition of PI3K and integrins (PI3K-Inh + ITG-Inh). The changes in invasive capacity following the combined inhibition of PI3K and integrins (PI3K-Inh + ITG-Inh) in PANC-1 and BXPC-3 cells. (O, P) Statistical data corresponding to (M, N) .

Journal: Frontiers in Oncology

Article Title: FN1 from cancer-associated fibroblasts orchestrates pancreatic cancer metastasis via integrin-PI3K/AKT signaling

doi: 10.3389/fonc.2025.1595523

Figure Lengend Snippet: The FN1-ITG-PI3K/AKT axis promotes invasion and migration of pancreatic cancer cells. (A, B) GEPIA database analysis revealing a significant positive correlation between FN1 expression and the expression of key genes in the PI3K/AKT pathway (PIK3CA, AKT1). (C, D) Western blot results showing changes in phosphorylation levels of p-AKT and p-PI3K in the FN1-Ab group. The Western blot results demonstrated the changes in the phosphorylation levels of p-AKT and p-PI3K in the FN1-Ab groups of PANC-1 and BXPC-3 cells. (E, F) Statistical data corresponding to (C, D) . (G, H) mRNA expression changes of integrin genes (ITGA2, ITGB4, ITGA3) before and after treatment with an integrin inhibitor (ITG-Inh). The changes in mRNA expression of integrin genes ITGA2 , ITGB4 , and ITGA3 in PANC-1 and BXPC-3 cells before and after treatment with the integrin inhibitor ITG-Inh. (I, J) Western blot results demonstrating changes in protein levels of p-AKT and p-PI3K in the ITG-Inh group compared to the control group (ITG-Con). The Western blot results indicated that in PANC-1 and BXPC-3 cells, compared with the control group (ITG-CON), the protein levels of p-AKT and p-PI3K in the ITG-Inh group were altered. (K, L) Statistical data corresponding to (I, J) . (M, N) Changes in invasion ability after combined inhibition of PI3K and integrins (PI3K-Inh + ITG-Inh). The changes in invasive capacity following the combined inhibition of PI3K and integrins (PI3K-Inh + ITG-Inh) in PANC-1 and BXPC-3 cells. (O, P) Statistical data corresponding to (M, N) .

Article Snippet: FN1 neutralizing antibody (FN1-Ab) was purchased from R&D Systems (Cat# MAB19182).

Techniques: Migration, Expressing, Western Blot, Phospho-proteomics, Control, Inhibition

High FN1 expression is associated with poor prognosis and an immunosuppressive microenvironment. (A) Clinical data analysis showing the relationship between FN1 expression and patient survival. (B) TIMER2.0 displaying the correlation between FN1 expression and M2 macrophage infiltration in pancreatic cancer (PAAD). (C) TIMER2.0 showing the correlation between FN1 expression and Treg cell infiltration in PAAD. (D) Mechanism diagram illustrating how FN1 activates the PI3K/AKT pathway by binding to integrin receptors, thereby promoting the invasion and metastasis of pancreatic cancer cells.

Journal: Frontiers in Oncology

Article Title: FN1 from cancer-associated fibroblasts orchestrates pancreatic cancer metastasis via integrin-PI3K/AKT signaling

doi: 10.3389/fonc.2025.1595523

Figure Lengend Snippet: High FN1 expression is associated with poor prognosis and an immunosuppressive microenvironment. (A) Clinical data analysis showing the relationship between FN1 expression and patient survival. (B) TIMER2.0 displaying the correlation between FN1 expression and M2 macrophage infiltration in pancreatic cancer (PAAD). (C) TIMER2.0 showing the correlation between FN1 expression and Treg cell infiltration in PAAD. (D) Mechanism diagram illustrating how FN1 activates the PI3K/AKT pathway by binding to integrin receptors, thereby promoting the invasion and metastasis of pancreatic cancer cells.

Article Snippet: FN1 neutralizing antibody (FN1-Ab) was purchased from R&D Systems (Cat# MAB19182).

Techniques: Expressing, Binding Assay

A. UMAP clustering of combined Xenium data sets from diabetic db/db and diabetic mice treated with DAPA for 6 weeks (n=4). B. Dot plot showing the cell specific markers from combined analysis of Xenium data sets. C. UMAP plot showing clustering of different cell types in aorta from db/db and db/dbDAPA mice. D. Representative Xenium data showing distribution of cell specific markers of SMC ( Myh11 ), fibroblast ( Dcn ) and endothelial cells ( Pecam1 ) in a representative aorta from one of the db/dbDAPA mice. E. Aortic cell clusters are depicted clearly in aortic sections in Xenium data sets from db/db and db/dbDAPA group. F-H. Representative images of Xenium data from db/db and db/dbDAPA aortas showing the expression of contractile ( Myh11 ) and Fibrosis markers ( Fn1 and Col1a1 ). I-L. Violin plots depicting expression of contractile ( Myh11 , Acta2 ), and fibrosis associated genes ( Fn1, Col1a1 ) in db/db and db/dbDAPA groups (showing DAPA reduces Col1a1 fibrosis marker).

Journal: Arteriosclerosis, thrombosis, and vascular biology

Article Title: Single-Cell Multimodal Profiling Highlights Persistent Aortic Smooth Muscle Cell Changes in Diabetic Mice Despite Glycemic Control

doi: 10.1161/ATVBAHA.125.324012

Figure Lengend Snippet: A. UMAP clustering of combined Xenium data sets from diabetic db/db and diabetic mice treated with DAPA for 6 weeks (n=4). B. Dot plot showing the cell specific markers from combined analysis of Xenium data sets. C. UMAP plot showing clustering of different cell types in aorta from db/db and db/dbDAPA mice. D. Representative Xenium data showing distribution of cell specific markers of SMC ( Myh11 ), fibroblast ( Dcn ) and endothelial cells ( Pecam1 ) in a representative aorta from one of the db/dbDAPA mice. E. Aortic cell clusters are depicted clearly in aortic sections in Xenium data sets from db/db and db/dbDAPA group. F-H. Representative images of Xenium data from db/db and db/dbDAPA aortas showing the expression of contractile ( Myh11 ) and Fibrosis markers ( Fn1 and Col1a1 ). I-L. Violin plots depicting expression of contractile ( Myh11 , Acta2 ), and fibrosis associated genes ( Fn1, Col1a1 ) in db/db and db/dbDAPA groups (showing DAPA reduces Col1a1 fibrosis marker).

Article Snippet: For fibronectin 1 (FN1) IHC, the sections were incubated with anti-FN1 rabbit polyclonal primary antibody (1:300, cat# 15613–1-AP, Proteintech), followed by goat anti-rabbit secondary antibody (1:200, cat# BA-1000, Invitrogen).

Techniques: Spatial Transcriptomics, Expressing, Marker